1987
DOI: 10.1016/s0021-9258(18)48190-2
|View full text |Cite
|
Sign up to set email alerts
|

Spectroscopic studies on the interaction of phosphate with uteroferrin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
7
0

Year Published

1988
1988
1999
1999

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 24 publications
1
7
0
Order By: Relevance
“…Apparently the presence of the additional noncatalytic subunit protects the enzyme against oxidation during purification. Considerable controversy has surrounded the identification of a reduced phosphate complex, 139,141,142,144,145 and spectroscopic evidence to support its existence has only recently been obtained (vide infra).…”
Section: Ribonucleotide Reductasementioning
confidence: 99%
“…Apparently the presence of the additional noncatalytic subunit protects the enzyme against oxidation during purification. Considerable controversy has surrounded the identification of a reduced phosphate complex, 139,141,142,144,145 and spectroscopic evidence to support its existence has only recently been obtained (vide infra).…”
Section: Ribonucleotide Reductasementioning
confidence: 99%
“…Several oxoanions are inhibitors of uteroferrin. ,,, Phosphate (PO 4 3- ) , and arsenate (AsO 4 3- ) 22,45,56 are competitive inhibitors which lower the reduction potential and lead to aerobic oxidation of the site to the inactive met level ,, Molybdate (MoO 4 2- ) 49,74 and tungstate (WO 4 2- ) 74 are noncompetitive inhibitors, which are thought to interact with the active site in a different manner due to their much larger binding constants. , These anions increase the reduction potential and stabilize the half-met site .…”
Section: Introductionmentioning
confidence: 99%
“…Several oxoanions are inhibitors of uteroferrin. 42,45,51,52 Phosphate (PO 4 3-) 22, [53][54][55][56] and arsenate (AsO 4 3-) 22,45,56 are competitive inhibitors which lower the reduction potential 57 and lead to aerobic oxidation of the site to the inactive met level. 51 Magnetic susceptibility studies show that 1/2metUf has a much weaker antiferromagnetic coupling between the metal sites after the phosphate binding 36,38 and a dramatically altered EPR signal that is broad and difficult to observe.…”
Section: Introductionmentioning
confidence: 99%
“…Phosphate is known to inhibit the reduced enzyme reversibly without the presence of oxygen, and this phosphate can be removed reversibly from PAP. Since vanadate is a phosphate analog, similar modes of interaction may take place between the purple acid phosphatase and vanadate Doi et al, 1987;Pyrz et al, 1986;Day et al, 1988; David & Que, 1990; Wang et al, 1991), and the nature of the interaction is explored in further detail below.…”
Section: Inhibition Of Purple Acid Phosphatase By Vanadatementioning
confidence: 99%
“…Anion interactions with the purple acid phosphatases (PAPs) are particularly important for understanding the detailed mechanism of phosphate ester hydrolysis (Vincent & Averill 1991;Doi et al, 1987). PAPs are distinguished from other phosphatases because PAP contains a diiron center that can exist in two oxidation states: a catalytically active Fe(II)-Fe(III) form and an inactive Fe(III)-Fe(III) form.…”
mentioning
confidence: 99%